- Home
- XPEV vs PEN Comparison
XPEV vs PEN Comparison
Compare XPEV & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XPEV
- PEN
- Stock Information
- Founded
- XPEV 2015
- PEN 2004
- Country
- XPEV China
- PEN United States
- Employees
- XPEV N/A
- PEN N/A
- Industry
- XPEV Auto Manufacturing
- PEN Medical/Dental Instruments
- Sector
- XPEV Consumer Discretionary
- PEN Health Care
- Exchange
- XPEV Nasdaq
- PEN Nasdaq
- Market Cap
- XPEV 12.0B
- PEN 10.0B
- IPO Year
- XPEV 2020
- PEN 2015
- Fundamental
- Price
- XPEV $18.43
- PEN $291.61
- Analyst Decision
- XPEV Buy
- PEN Buy
- Analyst Count
- XPEV 8
- PEN 16
- Target Price
- XPEV $13.84
- PEN $287.07
- AVG Volume (30 Days)
- XPEV 10.7M
- PEN 524.6K
- Earning Date
- XPEV 03-18-2025
- PEN 02-18-2025
- Dividend Yield
- XPEV N/A
- PEN N/A
- EPS Growth
- XPEV N/A
- PEN N/A
- EPS
- XPEV N/A
- PEN 0.36
- Revenue
- XPEV $5,390,497,248.00
- PEN $1,194,615,000.00
- Revenue This Year
- XPEV $36.06
- PEN $13.65
- Revenue Next Year
- XPEV $74.76
- PEN $14.30
- P/E Ratio
- XPEV N/A
- PEN $801.77
- Revenue Growth
- XPEV 66.09
- PEN 12.86
- 52 Week Low
- XPEV $6.55
- PEN $148.00
- 52 Week High
- XPEV $19.36
- PEN $310.00
- Technical
- Relative Strength Index (RSI)
- XPEV 69.24
- PEN 65.03
- Support Level
- XPEV $17.46
- PEN $264.82
- Resistance Level
- XPEV $18.29
- PEN $310.00
- Average True Range (ATR)
- XPEV 0.70
- PEN 7.93
- MACD
- XPEV 0.11
- PEN 2.79
- Stochastic Oscillator
- XPEV 79.78
- PEN 64.07
About XPEV XPeng Inc.
Founded in 2015, XPeng is a leading Chinese smart electric vehicle company that designs, develops, manufactures, and markets EVs in China. Its products primarily target the growing base of technology-savvy middle-class consumers in the midrange to high-end segment in China's passenger vehicle market. The company sold over 141,000 EVs in 2023, accounting for about 2% of China's passenger new energy vehicle market. It is also a leader in autonomous driving technology.
About PEN Penumbra Inc.
Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians. The neurovascular product category contributes to the majority of revenue. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. Penumbra generates the majority of its revenue in the United States.